Washington – The Trump administration’s pledge to “reshore” pharmaceutical manufacturing is running into a stark reality check in the Deep South. A once‑busy generic‑drug factory in St. Bernard Parish, Louisiana, has been idle for more than two years, underscoring the technical, economic and regulatory hurdles that any effort to revive domestic...